Shukra Pharmaceuticals fundamental analysis

SHUKRAPHAR

38.25

1.48 (-3.73%)
Last updated on 2 Feb, 2026 | 12:55 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Shukra Pharmaceuticals Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

65.25

Sector P/B

1.2

Sec. Div. Yield

0.58

Shukra Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 65.25. Its P/B Ratio stands at 0, while the sector’s is 1.2. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.58%.

Shukra Pharmaceuticals Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Shukra Pharmaceuticals reflects: Price – Expensive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.